News

Off-label Low-Dose Naltrexone Reduced Fibromyalgia Pain


 

FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF PAIN MEDICINE

Approximately 5% of U.S. women and 2% of men are thought to have fibromyalgia.

Dr. Younger reported having no financial disclosures. Funding for the study came primarily from the American Fibromyalgia Syndrome Association, with other support from Jim and Connie Binns, the Oxnard Foundation, the Chris Redlich Pain Research Endowment, and the Rosekran Pain Research Endowment.

Pages

Recommended Reading

Spine Pain + Fibromyalgia Flag Resistance to Standard Therapy
MDedge Internal Medicine
Stratify Patients for Opioid Misuse and Abuse Risk
MDedge Internal Medicine
Acupuncture Flops as Relief for Muscle Pain From Aromatase Inhibitors
MDedge Internal Medicine
FDA Issues One REMS for All Transmucosal Fentanyl
MDedge Internal Medicine
Spot Lumbar Spinal Stenosis From Across the Room
MDedge Internal Medicine
FDA Panel: Pain Patch Not Yet Approvable for HIV Neuropathy
MDedge Internal Medicine
Physicians Often Missing Boat on Gout Therapy
MDedge Internal Medicine
Less NSAIDs for Arthritis Equals More Falls
MDedge Internal Medicine
Her Chief Complaint Is ... And by the Way She’s Also Pregnant
MDedge Internal Medicine
Neck Pain in Primary Care: What Can We Do Better?
MDedge Internal Medicine